| - SMTL ID
- 2vwm.1
- Ligands
- (4R)-4-{[(5-chlorothiophen-2-yl)carbonyl]amino}-N-(cyclopropylmethyl)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)-L-prolinamide; SODIUM ION
- Polypeptides
- ACTIVATED FACTOR XA HEAVY CHAIN; FACTOR X LIGHT CHAIN
- Oligo-state
- hetero-1-1-mer
|
| - SMTL ID
- 2vwm.2
- Ligands
- (4R)-4-{[(5-chlorothiophen-2-yl)carbonyl]amino}-N-(cyclopropylmethyl)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)-L-prolinamide; SODIUM ION
- Polypeptides
- ACTIVATED FACTOR XA HEAVY CHAIN; FACTOR X LIGHT CHAIN
- Oligo-state
- hetero-1-1-mer
|
| - SMTL ID
- 2vwm.3
- Ligands
- (4R)-4-{[(5-chlorothiophen-2-yl)carbonyl]amino}-N-(cyclopropylmethyl)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)-L-prolinamide; SODIUM ION
- Polypeptides
- ACTIVATED FACTOR XA HEAVY CHAIN
- Oligo-state
- monomer
|
| - SMTL ID
- 2vwm.4
- Ligands
- -
- Polypeptides
- FACTOR X LIGHT CHAIN
- Oligo-state
- monomer
|
| - SMTL ID
- 2vwm.5
- Ligands
- (4R)-4-{[(5-chlorothiophen-2-yl)carbonyl]amino}-N-(cyclopropylmethyl)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)-L-prolinamide; SODIUM ION
- Polypeptides
- ACTIVATED FACTOR XA HEAVY CHAIN
- Oligo-state
- monomer
|
| - SMTL ID
- 2vwm.6
- Ligands
- -
- Polypeptides
- FACTOR X LIGHT CHAIN
- Oligo-state
- monomer
|